Newbury Pharmaceuticals AB (publ) (NEWBRY.ST)
Newbury Pharmaceuticals AB (publ) operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Lund, SN, SE. The stock last traded at $2.31, up 0.43% on the session, giving a market capitalisation of $59.9M. Its beta of 1.25 implies it has historically moved more than the broad market.
Newbury Pharmaceuticals AB (publ), a hybrid pharmaceutical enterprise, serves both the Swedish and wider Scandinavian markets. Formed in 2020 and headquartered in Lund, Sweden, the company provides a variety of therapeutic solutions, with a strong emphasis on oncology, rare diseases, and neurology, in addition to other treatment categories.
Newbury Pharmaceuticals AB (publ) is most often compared with the following Healthcare names: